Success Metrics

Clinical Success Rate
78.6%

Based on 11 completed trials

Completion Rate
79%(11/14)
Active Trials
1(7%)
Results Posted
45%(5 trials)
Terminated
3(20%)

Phase Distribution

Ph phase_4
1
7%
Ph not_applicable
3
20%
Ph phase_1
7
47%
Ph phase_2
1
7%
Ph phase_3
2
13%

Phase Distribution

7

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
7(50.0%)
Phase 2Efficacy & side effects
1(7.1%)
Phase 3Large-scale testing
2(14.3%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
3(21.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.6%

11 of 14 finished

Non-Completion Rate

21.4%

3 ended early

Currently Active

1

trials recruiting

Total Trials

15

all time

Status Distribution
Active(1)
Completed(11)
Terminated(3)

Detailed Status

Completed11
Terminated3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
1
Success Rate
78.6%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (50.0%)
Phase 21 (7.1%)
Phase 32 (14.3%)
Phase 41 (7.1%)
N/A3 (21.4%)

Trials by Status

recruiting17%
terminated320%
completed1173%

Recent Activity

1 active trials
Showing 5 of 15
recruitingnot_applicable

Dextromethorphan for Treatment of Postoperative Pain

NCT05278494
terminatedphase_4

Dextromethorphan Pediatric Acute Cough Study

NCT02651116
completedphase_3

Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion

NCT03480009
completedphase_1

Dextromethorphan for Diabetic Macular Edema

NCT01441102
completedphase_3

Treatment for Chronic Pain in Patients With Advanced Cancer

NCT00003687
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT05278494Not Applicable

Dextromethorphan for Treatment of Postoperative Pain

Recruiting
NCT02651116Phase 4

Dextromethorphan Pediatric Acute Cough Study

Terminated
NCT03480009Phase 3

Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion

Completed
NCT01441102Phase 1

Dextromethorphan for Diabetic Macular Edema

Completed
NCT00003687Phase 3

Treatment for Chronic Pain in Patients With Advanced Cancer

Completed
NCT02860962Phase 1

A Trial of Dextromethorphan for Treatment of Major Depressive Disorder

Completed
NCT00873366

Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

Terminated
NCT02368093Not Applicable

Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis

Completed
NCT01218620Phase 1

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors

Completed
NCT02256813Phase 1

Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers

Completed
NCT02243553Phase 1

Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers

Completed
NCT02182336Phase 1

Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers

Completed
NCT01017939Phase 1

A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer

Completed
NCT01441986Phase 2

Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects

Completed
NCT00176540Not Applicable

Dextromethorphan in Treating Patients With Fatigue Caused by Cancer

Terminated

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15